Navigation Links
Myriant Technologies LLC Announces Appointment of Science Advisory Board Members
Date:10/21/2009

QUINCY, Mass., Oct. 21 /PRNewswire/ -- Myriant Technologies LLC (Myriant), a privately-held, biotech developer and manufacturer of renewable biochemicals, announced the formation of its Science Advisory Board and the appointment of distinguished Board members. Board members individually and collectively will provide broad insight into all aspects of the technology and business of converting renewable biomass feedstocks into valuable chemicals.

(Logo: http://www.newscom.com/cgi-bin/prnh/20091021/NE96331LOGO )

Collectively, the Board members have outstanding credentials as scientists in the biotechnology fields of specific interest to Myriant, including: molecular biology, genetic and metabolic pathway engineering, micro-organism development and related fermentation process development.

Myriant's Science Advisory Board members include:

  • Dr. Stephen J. Benkovic, Evan Pugh Professor and Eberly Chair in Chemistry at Penn State University, and member of the National Academy of Sciences and its Institute of Medicine;
  • Dr. Joseph Glas, Executive Vice President and Advisory Board Chairman, Myriant;
  • Dr. Lonnie Ingram, Distinguished Professor, Department of Microbiology and Cell Science, University of Florida, and Director, Florida Center for Renewable Chemicals and Fuels, and member of the National Academy of Sciences;
  • Dr. Jan Westpheling, Professor, Department of Genetics, University of Georgia; and
  • Dr. Huimin Zhao, Professor, Centennial Endowed Chair of Chemical and Biomolecular Engineering, University of Illinois.

"I am honored and we are fortunate to have such an exceptional group of scientists as advisors to Myriant," said Stephen J. Gatto, Chairman and Chief Executive Officer of Myriant. "Under the leadership of Dr. Joe Glas, I have great confidence that we will reap immediate and long term benefits from their advice and input."

"The pace of change in Myriant's field of industrial biotechnology is ever accelerating," added Dr. Glas. "Our cutting-edge research and development team will benefit enormously from the addition of this unique expertise and its impact on our paths to commercialization."

With a world-renowned team of molecular biologists, engineers and chemists, Myriant utilizes proprietary technology to advance the development of low-cost cellulosic sugars for the sustainable commercialization of high-value specialty chemicals. The company's D(-) lactic acid started production at commercial scale in June 2008 for use in polylactic acid. Myriant will begin commercial production of its second product, biobased succinic acid, in 2010. Myriant is headquartered in Quincy, Massachusetts. Further information is available at www.myriant.com.

    Contact: Samuel G. McConnell
    Sr. VP, Corporate Development
    617-657-5207

SOURCE Myriant Technologies LLC


'/>"/>
SOURCE Myriant Technologies LLC
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. BioEnergy International, LLC Announces Formation of Myriant Technologies LLC
2. China Medical Technologies to Exhibit its Products at China International Medical Equipment Fair in Chengdu, China
3. Epeius Biotechnologies to Partner at BIO Investor Forum
4. Neurobiological Technologies Announces Intent to File Form 25 to Delist Common Stock From the NASDAQ Capital Market
5. OriGene Technologies Acquires Marligen Biosciences
6. China Medical Technologies Announces the SFDA Approval for its SPR System
7. Global Med Technologies(R), Inc. Licenses EdgeLab to Seven Laboratories at University Hospital of Reims, France
8. Varian, Inc. Announces Stockholder Approval of Merger Agreement With Agilent Technologies
9. TOPAZ Technologies Protocols for Animal Studies Software Drives Customer Conversions
10. Global Med Technologies(R) Signs Binding LOI With European Company for Breakthrough Transfusion Safety RFID Product
11. Variation Biotechnologies Names Jeff Baxter CEO
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... BioMarketing, a leading provider of patient support solutions, has announced ... network, which will launch this week. The VMS CNEs will ... to enhance the patient care experience by delivering peer-to-peer education ... professionals to help women who have been diagnosed and are ... ...
(Date:10/10/2017)... (PRWEB) , ... October 10, 2017 , ... San Diego-based ... of its corporate rebranding initiative announced today. The bold new look is part ... as the company moves into a significant growth period. , It will also expand ...
(Date:10/10/2017)... CRUZ, Calif. , Oct. 10, 2017 ... grant from the NIH to develop RealSeq®-SC (Single Cell), ... kit for profiling small RNAs (including microRNAs) from single ... Analysis Program highlights the need to accelerate development of ... "New techniques for measuring ...
(Date:10/9/2017)... ... ... At its national board meeting in North Carolina, ARCS® Foundation ... Physics and Astronomy, has been selected for membership in ARCS Alumni Hall of ... Breakthrough Prize in Fundamental physics for the discovery of the accelerating expansion of the ...
Breaking Biology Technology:
(Date:4/5/2017)... -- The Allen Institute for Cell Science today announces the ... and dynamic digital window into the human cell. The ... of deep learning to create predictive models of cell ... growing suite of powerful tools. The Allen Cell Explorer ... available resources created and shared by the Allen Institute ...
(Date:4/4/2017)... 2017   EyeLock LLC , a leader of ... States Patent and Trademark Office (USPTO) has issued U.S. ... of an iris image with a face image acquired ... company,s 45 th issued patent. ... given the multi-modal biometric capabilities that have recently come ...
(Date:3/30/2017)... 2017 The research team of The Hong ... fingerprint identification by adopting ground breaking 3D fingerprint minutiae recovery and ... speed and accuracy for use in identification, crime investigation, immigration control, ... ... A research team led ...
Breaking Biology News(10 mins):